Skip to main content
OpenTrials
Completed

NCT Number: NCT06037707

Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit

The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19-Associated Thromboembolism COVID-19 Cardiovascular Diseases Coronaviridae Infections Coronavirus Infections Embolism and Thrombosis Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Thromboembolism Vascular Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Derince Research and Training Hospital

Kocaeli, Derince, 41900, Turkey (Türkiye)

About this study

Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021

Exclusion criteria

  • who is under 18 years old.

Treatment and study plan

Primary outcomes

  1. Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

    Time frame: During the entire intensive care stay up to 1 day

    Both arterial and venous thromboembolic events were detected

Secondary outcomes

  1. Rate of thromboembolic complications of COVID-19 disease in critically ill patients

    Time frame: During the entire intensive care stay up to 1 day

    Both arterial and venous thromboembolic events were detected

  2. Rate of thromboembolic complications according to anticoagulant therapy

    Time frame: During the entire intensive care stay up to 1 day

    Antithrombotic therapy of each patient was recorded

  3. What is the rate of thromboembolism according to the comorbidities

    Time frame: During the entire intensive care stay up to 1 day

    Comorbidities of each patient were recorded from the patients records.

Sponsors and collaborators

Lead sponsor

Ayse Zeynep Turan

Other

Registry information

Official study title

Incidence of Thromboembolism in COVID-19 Infection in the ICU: a Retrospective Cohort Analysis

Acronym: COVID-19TC

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Sep 14, 2023
Registry last updated
Jan 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.